Published in Cancer Weekly, November 1st, 2011
"Unlike CTCF, BORIS expression has been reported only in the testis and certain malignancies, leading to its classification as a 'cancer-testis'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.